Belzutifan acts as a HIF-2 pseudo-inhibitor, zeroing in on VHL-related RCC and designed to cut down tumor hypoxia signals. The drug comes as 40mg film-coated tabs, and the usual advice is to take 120mg per day, just one pill a day.
Each bottle you get has 90 of these tabs.
Reviews
There are no reviews yet.